MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11845-026-04530-9

Медицинская библиотека · Irish journal of medical science · 2026

Weight-adjusted adenosine and first-dose conversion success in supraventricular tachycardia: a prospective cohort study.

Satici Merve Osoydan, Aksel Gökhan, İslam Mehmet Muzaffer, Erdil Gündüz Fahriye Naz, Tarakçıoğlu Dilşa, Eker Nevin, Küka Burak, Gündüz Alper Reşit, Güneş Ahmed, Anıl Muhammed Arda, Altın Ceyda, Eroğlu Serkan Emre

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Current guidelines recommend a standard fixed initial dose of 6 mg adenosine for supraventricular tachycardia (SVT). However, rising obesity rates may reduce the efficacy of this fixed-dose strategy. We aimed to evaluate the impact of body weight on first-dose adenosine success and to identify an optimal weight-adjusted dose.

METHODS

This prospective observational study included 155 adult SVT patients refractory to vagal maneuvers at a tertiary emergency department (ED). All patients received an initial 6 mg dose of IV adenosine. Success was defined as conversion to sinus rhythm (SR). Weight-adjusted doses (mg/kg) were compared between success and failure groups, and ROC analysis was performed to identify optimal cutoffs.

RESULTS

The first-dose conversion rate was 58.1%. Patients with successful conversion had significantly lower body weight (74.0 ± 14.3 kg vs. 81.9 ± 16.2 kg, p = 0.001). The weight-adjusted dose was significantly higher in the success group compared to the failure group (0.082 vs. 0.074 mg/kg, p < 0.001). ROC analysis revealed that a weight-adjusted dose ≥ 0.076 mg/kg predicted conversion with 67.8% sensitivity and 60.0% specificity. Specificity increased to 90.8% at a cutoff of ≥ 0.10 mg/kg.

CONCLUSION

Our findings suggest that the standard fixed 6 mg initial dose of adenosine may be insufficient for contemporary populations with higher body weight. A weight-adjusted initial dose, particularly targeting 0.09-0.1 mg/kg, may optimize first-dose conversion to sinus rhythm in patients with SVT.

Для цитирования: Satici Merve Osoydan, Aksel Gökhan, İslam Mehmet Muzaffer, Erdil Gündüz Fahriye Naz, Tarakçıoğlu Dilşa, Eker Nevin, Küka Burak, Gündüz Alper Reşit, Güneş Ahmed, Anıl Muhammed Arda, Altın Ceyda, Eroğlu Serkan Emre. Weight-adjusted adenosine and first-dose conversion success in supraventricular tachycardia: a prospective cohort study.. Irish journal of medical science. 2026. DOI: 10.1007/s11845-026-04530-9.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.